OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Pharmaceutics is 59. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial Board	396
A quantification of gastric and duodenal fluid volumes in older adults using MRI	178
Evaluation of a polymeric topical formulation of Endoxifen in an estrogen receptor positive breast cancer murine model	158
Editorial Board	148
Vesicular phospholipid gels: A new strategy to improve topical antimicrobial dermatotherapy	144
Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations	136
Ophthalmic wild olive (ACEBUCHE) oil nanoemulsions exert oculoprotective effects against oxidative stress induced by arterial hypertension	130
Editorial Board	123
A smart β-Cyclodextrin-Aza[5]Helicene system for enhanced gemcitabine delivery and tracking in cancer cells	114
An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable	109
Editorial Board	101
Corrigendum to “Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect” [Int. J. Pharm. 652 (2024) 123802]	91
Corrigendum to “Mechanistic modeling of twin screw wet granulation for pharmaceutical formulations: Calibration, sensitivity analysis, and model-driven workflow” [Int. J. Pharm. 659 (2024) 124246]	87
Oxygen Sensitive Drug Release Using Hemoglobin Microbubbles: A New Approach to Targeting Hypoxia in Ultrasound-Mediated Drug Delivery	86
Encapsulation of Combretastatin A-4 in Sub-10 nm unimer micelles to improve its aqueous stability and anticancer activity	86
ERAP2 inhibitor −incorporated nanofibers: Characterization and biological assessment	84
Electrosprayed co-crystals of levofloxacin for inhalation: a strategy for excipient-free dry powder antibiotics	84
Bone-targeting lipid-polymer hybrid nanoparticles for less invasive, injectable local antibiotic treatment of bone infections by methicillin-resistant Staphylococcus aureus (MRSA)	80
pH-sensitive niosomes for ATRA delivery: A promising approach to inhibit Pin1 in high-grade serous ovarian cancer	79
Lyophilized liposomal formulation of a peptidomimetic-Dox conjugate for HER2 positive breast and lung cancer	78
Editorial Board	77
Overview of biomembrane-derived nanoparticles as emerging drug delivery systems for treating bone aging diseases	77
Comparative dissolution studies of 3D-printed inserts in a novel biopharmaceutical bladder model	77
Lactoferrin decorated bilosomes for the oral delivery of quercetin in type 2 diabetes: In vitro and in vivo appraisal	76
Plasminogen–cyclodextrin aerosol for ARDS: activity retention in simulated oxygen therapy and inflammation-triggered clot lysis	76

In vivo and in vitro transdermal availability of Ibuprofen using novel solubility enhancing fluid nanosized carrier systems	73
A material-sparing simplified buoyancy method for determining the true density of solids	71
An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting	69
4D study of liquid binder penetration dynamics in pharmaceutical powders using synchrotron X-ray micro computed tomography	69
Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration	68
Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment	68
Increased bioavailability of a P-gp substrate: Co-release of etoposide and zosuquidar from amorphous solid dispersions	68
Heme oxygenase 1 inhibitor discovery and formulation into nanostructured lipid carriers as potent and selective treatment against triple negative metastatic breast cancer	68
Recent advancements in aptamer-mediated theranostics in the management of hematological disorders	68
Development of iron oxide based-upconversion nanocomposites for cancer therapeutics treatment	67
DNA-templated nanosheets for enhanced chemodynamic therapy and gene therapy to inhibit tumor recurrence and metastasis	67
Biomimetic replenishment therapy of cortisol using semi-solid extrusion – 3D printed tablets for adrenal insufficiencies	67
Characterization and bioavailability of a novel coenzyme Q10 nanoemulsion used as an infant formula supplement	67
Rapidly separable bubble microneedle-patch system present superior transdermal mRNA delivery efficiency	66
Enhanced dissolution rate of nimodipine through β-lactoglobulin based formulation	66
Simultaneous modeling prediction of three key quality attributes of tablets by powder physical properties	65
A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET/CT imaging of triple-negative breast cancer	65
Development of a predictive model for gravimetric powder feeding from an API-rich materials properties library	64
Systemic administration of a novel Beclin 1-derived peptide significantly upregulates autophagy in the spinal motor neurons of autophagy reporter mice	64
Tumor-specific targeting of polymer drug delivery systems with recombinant proteins bound via tris(nitrilotriacetic acid)	64
In situ gel-forming oil as rectally delivering platform of hydrophobic therapeutics for ulcerative colitis therapy	63
Editorial Board	63
Investigating stimuli-responsive liposomes for cutaneous applications: a guide to stimuli recognition and characterization	63
Personalised paediatric chewable Ibuprofen tablets fabricated using 3D micro-extrusion printing technology	63
Corrigendum to “Impact of polymer source variations on hydrogel structure and product performance in dexamethasone-loaded ophthalmic inserts” [Int. J. Pharm. 682 (2025) 125959]	63
mRNA therapeutics for inflammatory bone diseases: opportunity and challenge	62
A compartment model for subcutaneous injection of monoclonal antibodies	62
Methylcobalamin-loaded ultra-flexible liposomes: a nanocarrier approach for modulating melanocyte homeostasis and addressing pigmentation imbalances	61
Multifunctional nanomaterial-mediated tumor therapeutics: enhancing efficacy and specificity	61
Fractional ablative laser-enhanced transdermal delivery of vismodegib: systematic evaluation of microporation parameters and permeation kinetics	60
Efficacy and safety of nanoparticles of glibenclamide and organomodified layered double hydroxides in diabetics rats	60
Enhancement of in-vitro anti-oral cancer activities of silymarin using dispersion of nanostructured lipid carrier in mucoadhesive in-situ gel	59
Chitosan-aloe vera scaffolds with tuned extracellular vesicles and histatin-5 display osteogenic and anti-biofilm activities	59
Gypenoside A-loaded mPEG-PLGA nanoparticles ameliorate high-glucose-induced retinal microvasculopathy by inhibiting ferroptosis	59
Probing fluconazole deposition inside mesoporous silica using solid-state NMR spectroscopy: Crystallization of a confined metastable form and phase transformations under storage conditions	59